nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ABCB1—Methylprednisolone—psoriatic arthritis	0.115	0.144	CbGbCtD
Toremifene—CYP1A1—Dexamethasone—psoriatic arthritis	0.111	0.139	CbGbCtD
Toremifene—ABCB1—Betamethasone—psoriatic arthritis	0.0747	0.0934	CbGbCtD
Toremifene—ABCB1—Prednisolone—psoriatic arthritis	0.0737	0.0921	CbGbCtD
Toremifene—ABCB1—Prednisone—psoriatic arthritis	0.0696	0.087	CbGbCtD
Toremifene—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0688	0.086	CbGbCtD
Toremifene—CYP3A4—Triamcinolone—psoriatic arthritis	0.0522	0.0652	CbGbCtD
Toremifene—CYP3A4—Betamethasone—psoriatic arthritis	0.0448	0.0559	CbGbCtD
Toremifene—CYP3A4—Prednisolone—psoriatic arthritis	0.0442	0.0552	CbGbCtD
Toremifene—ABCB1—Dexamethasone—psoriatic arthritis	0.0434	0.0543	CbGbCtD
Toremifene—CYP3A4—Prednisone—psoriatic arthritis	0.0417	0.0521	CbGbCtD
Toremifene—ABCB1—Methotrexate—psoriatic arthritis	0.0349	0.0436	CbGbCtD
Toremifene—CYP3A4—Dexamethasone—psoriatic arthritis	0.026	0.0325	CbGbCtD
Toremifene—Leukopenia—Auranofin—psoriatic arthritis	0.00196	0.00982	CcSEcCtD
Toremifene—Glaucoma—Triamcinolone—psoriatic arthritis	0.00195	0.00977	CcSEcCtD
Toremifene—Appetite absent—Methotrexate—psoriatic arthritis	0.00195	0.00977	CcSEcCtD
Toremifene—Glaucoma—Methylprednisolone—psoriatic arthritis	0.00195	0.00975	CcSEcCtD
Toremifene—Embolism—Prednisone—psoriatic arthritis	0.00181	0.00906	CcSEcCtD
Toremifene—Glaucoma—Betamethasone—psoriatic arthritis	0.00177	0.00887	CcSEcCtD
Toremifene—Glaucoma—Dexamethasone—psoriatic arthritis	0.00177	0.00887	CcSEcCtD
Toremifene—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00175	0.00877	CcSEcCtD
Toremifene—Anorexia—Auranofin—psoriatic arthritis	0.00171	0.00853	CcSEcCtD
Toremifene—Polyp—Methotrexate—psoriatic arthritis	0.0016	0.00799	CcSEcCtD
Toremifene—Deep vein thrombosis—Methotrexate—psoriatic arthritis	0.0016	0.00799	CcSEcCtD
Toremifene—Vaginal discharge—Methotrexate—psoriatic arthritis	0.0016	0.00799	CcSEcCtD
Toremifene—Decreased appetite—Auranofin—psoriatic arthritis	0.00156	0.00778	CcSEcCtD
Toremifene—Cataract—Triamcinolone—psoriatic arthritis	0.00155	0.00773	CcSEcCtD
Toremifene—Glaucoma—Prednisone—psoriatic arthritis	0.00154	0.00772	CcSEcCtD
Toremifene—Constipation—Auranofin—psoriatic arthritis	0.00153	0.00766	CcSEcCtD
Toremifene—Embolism—Methotrexate—psoriatic arthritis	0.00151	0.00757	CcSEcCtD
Toremifene—Cyst—Methotrexate—psoriatic arthritis	0.00145	0.00727	CcSEcCtD
Toremifene—Liver disorder—Methotrexate—psoriatic arthritis	0.00142	0.00713	CcSEcCtD
Toremifene—Cataract—Betamethasone—psoriatic arthritis	0.0014	0.00701	CcSEcCtD
Toremifene—Cataract—Dexamethasone—psoriatic arthritis	0.0014	0.00701	CcSEcCtD
Toremifene—Thrombophlebitis—Prednisolone—psoriatic arthritis	0.00134	0.00671	CcSEcCtD
Toremifene—Pruritus—Auranofin—psoriatic arthritis	0.00127	0.00633	CcSEcCtD
Toremifene—Thrombophlebitis—Triamcinolone—psoriatic arthritis	0.00123	0.00617	CcSEcCtD
Toremifene—Dry eye—Dexamethasone—psoriatic arthritis	0.00123	0.00617	CcSEcCtD
Toremifene—Dry eye—Betamethasone—psoriatic arthritis	0.00123	0.00617	CcSEcCtD
Toremifene—Thrombophlebitis—Methylprednisolone—psoriatic arthritis	0.00123	0.00616	CcSEcCtD
Toremifene—Cataract—Prednisone—psoriatic arthritis	0.00122	0.00611	CcSEcCtD
Toremifene—Affect lability—Prednisolone—psoriatic arthritis	0.00114	0.00572	CcSEcCtD
Toremifene—Vomiting—Auranofin—psoriatic arthritis	0.00114	0.00569	CcSEcCtD
Toremifene—Rash—Auranofin—psoriatic arthritis	0.00113	0.00564	CcSEcCtD
Toremifene—Dermatitis—Auranofin—psoriatic arthritis	0.00113	0.00564	CcSEcCtD
Toremifene—Thrombophlebitis—Dexamethasone—psoriatic arthritis	0.00112	0.0056	CcSEcCtD
Toremifene—Thrombophlebitis—Betamethasone—psoriatic arthritis	0.00112	0.0056	CcSEcCtD
Toremifene—Mood swings—Prednisolone—psoriatic arthritis	0.0011	0.0055	CcSEcCtD
Toremifene—Cardiac failure—Methylprednisolone—psoriatic arthritis	0.00109	0.00546	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Methotrexate—psoriatic arthritis	0.00108	0.00542	CcSEcCtD
Toremifene—Skin discolouration—Methotrexate—psoriatic arthritis	0.00108	0.00538	CcSEcCtD
Toremifene—Nausea—Auranofin—psoriatic arthritis	0.00106	0.00532	CcSEcCtD
Toremifene—Affect lability—Triamcinolone—psoriatic arthritis	0.00105	0.00526	CcSEcCtD
Toremifene—Affect lability—Methylprednisolone—psoriatic arthritis	0.00105	0.00525	CcSEcCtD
Toremifene—Mood swings—Triamcinolone—psoriatic arthritis	0.00101	0.00506	CcSEcCtD
Toremifene—Mood swings—Methylprednisolone—psoriatic arthritis	0.00101	0.00505	CcSEcCtD
Toremifene—Cardiac failure—Dexamethasone—psoriatic arthritis	0.000993	0.00497	CcSEcCtD
Toremifene—Cardiac failure—Betamethasone—psoriatic arthritis	0.000993	0.00497	CcSEcCtD
Toremifene—Lethargy—Betamethasone—psoriatic arthritis	0.000988	0.00495	CcSEcCtD
Toremifene—Lethargy—Dexamethasone—psoriatic arthritis	0.000988	0.00495	CcSEcCtD
Toremifene—Thrombophlebitis—Prednisone—psoriatic arthritis	0.000975	0.00488	CcSEcCtD
Toremifene—Pulmonary embolism—Methotrexate—psoriatic arthritis	0.000971	0.00486	CcSEcCtD
Toremifene—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000963	0.00482	CcSEcCtD
Toremifene—Affect lability—Dexamethasone—psoriatic arthritis	0.000953	0.00477	CcSEcCtD
Toremifene—Affect lability—Betamethasone—psoriatic arthritis	0.000953	0.00477	CcSEcCtD
Toremifene—Mood swings—Dexamethasone—psoriatic arthritis	0.000918	0.00459	CcSEcCtD
Toremifene—Mood swings—Betamethasone—psoriatic arthritis	0.000918	0.00459	CcSEcCtD
Toremifene—Weight increased—Prednisolone—psoriatic arthritis	0.000913	0.00457	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.000882	0.00441	CcSEcCtD
Toremifene—Myocardial infarction—Prednisolone—psoriatic arthritis	0.000877	0.00439	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000877	0.00439	CcSEcCtD
Toremifene—Cardiac failure—Prednisone—psoriatic arthritis	0.000864	0.00432	CcSEcCtD
Toremifene—Lethargy—Prednisone—psoriatic arthritis	0.000861	0.00431	CcSEcCtD
Toremifene—Weight increased—Triamcinolone—psoriatic arthritis	0.00084	0.0042	CcSEcCtD
Toremifene—Weight increased—Methylprednisolone—psoriatic arthritis	0.000838	0.00419	CcSEcCtD
Toremifene—Affect lability—Prednisone—psoriatic arthritis	0.00083	0.00415	CcSEcCtD
Toremifene—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.000814	0.00407	CcSEcCtD
Toremifene—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.000811	0.00406	CcSEcCtD
Toremifene—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.000809	0.00405	CcSEcCtD
Toremifene—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000806	0.00403	CcSEcCtD
Toremifene—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.000806	0.00403	CcSEcCtD
Toremifene—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.000805	0.00403	CcSEcCtD
Toremifene—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000805	0.00403	CcSEcCtD
Toremifene—Mood swings—Prednisone—psoriatic arthritis	0.000799	0.004	CcSEcCtD
Toremifene—Sweating—Methylprednisolone—psoriatic arthritis	0.000787	0.00394	CcSEcCtD
Toremifene—Visual impairment—Prednisolone—psoriatic arthritis	0.000774	0.00387	CcSEcCtD
Toremifene—Weight increased—Dexamethasone—psoriatic arthritis	0.000762	0.00381	CcSEcCtD
Toremifene—Weight increased—Betamethasone—psoriatic arthritis	0.000762	0.00381	CcSEcCtD
Toremifene—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.000736	0.00368	CcSEcCtD
Toremifene—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.000736	0.00368	CcSEcCtD
Toremifene—Myocardial infarction—Betamethasone—psoriatic arthritis	0.000732	0.00366	CcSEcCtD
Toremifene—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.000732	0.00366	CcSEcCtD
Toremifene—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000732	0.00366	CcSEcCtD
Toremifene—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000732	0.00366	CcSEcCtD
Toremifene—Lethargy—Methotrexate—psoriatic arthritis	0.000719	0.0036	CcSEcCtD
Toremifene—Arrhythmia—Prednisolone—psoriatic arthritis	0.000717	0.00359	CcSEcCtD
Toremifene—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00071	0.00355	CcSEcCtD
Toremifene—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000689	0.00345	CcSEcCtD
Toremifene—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000669	0.00334	CcSEcCtD
Toremifene—Mood swings—Methotrexate—psoriatic arthritis	0.000668	0.00334	CcSEcCtD
Toremifene—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000664	0.00332	CcSEcCtD
Toremifene—Weight increased—Prednisone—psoriatic arthritis	0.000664	0.00332	CcSEcCtD
Toremifene—Ataxia—Methotrexate—psoriatic arthritis	0.000663	0.00332	CcSEcCtD
Toremifene—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00066	0.0033	CcSEcCtD
Toremifene—Vision blurred—Prednisolone—psoriatic arthritis	0.000659	0.0033	CcSEcCtD
Toremifene—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.000658	0.00329	CcSEcCtD
Toremifene—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000651	0.00326	CcSEcCtD
Toremifene—Visual impairment—Betamethasone—psoriatic arthritis	0.000646	0.00323	CcSEcCtD
Toremifene—Visual impairment—Dexamethasone—psoriatic arthritis	0.000646	0.00323	CcSEcCtD
Toremifene—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000646	0.00323	CcSEcCtD
Toremifene—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000641	0.00321	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000641	0.00321	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000637	0.00319	CcSEcCtD
Toremifene—Myocardial infarction—Prednisone—psoriatic arthritis	0.000637	0.00319	CcSEcCtD
Toremifene—Breast disorder—Methotrexate—psoriatic arthritis	0.000637	0.00319	CcSEcCtD
Toremifene—Vertigo—Prednisolone—psoriatic arthritis	0.000628	0.00314	CcSEcCtD
Toremifene—Eye disorder—Betamethasone—psoriatic arthritis	0.000626	0.00313	CcSEcCtD
Toremifene—Eye disorder—Dexamethasone—psoriatic arthritis	0.000626	0.00313	CcSEcCtD
Toremifene—Back pain—Triamcinolone—psoriatic arthritis	0.000622	0.00311	CcSEcCtD
Toremifene—Angiopathy—Dexamethasone—psoriatic arthritis	0.000608	0.00304	CcSEcCtD
Toremifene—Angiopathy—Betamethasone—psoriatic arthritis	0.000608	0.00304	CcSEcCtD
Toremifene—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000599	0.00299	CcSEcCtD
Toremifene—Arrhythmia—Betamethasone—psoriatic arthritis	0.000599	0.00299	CcSEcCtD
Toremifene—Alopecia—Dexamethasone—psoriatic arthritis	0.000592	0.00296	CcSEcCtD
Toremifene—Alopecia—Betamethasone—psoriatic arthritis	0.000592	0.00296	CcSEcCtD
Toremifene—Vertigo—Triamcinolone—psoriatic arthritis	0.000578	0.00289	CcSEcCtD
Toremifene—Vertigo—Methylprednisolone—psoriatic arthritis	0.000576	0.00288	CcSEcCtD
Toremifene—Oedema—Prednisolone—psoriatic arthritis	0.000571	0.00285	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000552	0.00276	CcSEcCtD
Toremifene—Eye disorder—Prednisone—psoriatic arthritis	0.000545	0.00273	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000542	0.00271	CcSEcCtD
Toremifene—Angiopathy—Prednisone—psoriatic arthritis	0.000529	0.00265	CcSEcCtD
Toremifene—Oedema—Triamcinolone—psoriatic arthritis	0.000525	0.00262	CcSEcCtD
Toremifene—Vertigo—Dexamethasone—psoriatic arthritis	0.000524	0.00262	CcSEcCtD
Toremifene—Vertigo—Betamethasone—psoriatic arthritis	0.000524	0.00262	CcSEcCtD
Toremifene—Arrhythmia—Prednisone—psoriatic arthritis	0.000521	0.00261	CcSEcCtD
Toremifene—Sweating—Methotrexate—psoriatic arthritis	0.000521	0.00261	CcSEcCtD
Toremifene—Insomnia—Prednisolone—psoriatic arthritis	0.000516	0.00258	CcSEcCtD
Toremifene—Alopecia—Prednisone—psoriatic arthritis	0.000516	0.00258	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000514	0.00257	CcSEcCtD
Toremifene—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000513	0.00257	CcSEcCtD
Toremifene—Mental disorder—Prednisone—psoriatic arthritis	0.000511	0.00256	CcSEcCtD
Toremifene—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000509	0.00254	CcSEcCtD
Toremifene—Malnutrition—Prednisone—psoriatic arthritis	0.000508	0.00254	CcSEcCtD
Toremifene—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000507	0.00254	CcSEcCtD
Toremifene—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000506	0.00253	CcSEcCtD
Toremifene—Pain—Prednisolone—psoriatic arthritis	0.000488	0.00244	CcSEcCtD
Toremifene—Vision blurred—Prednisone—psoriatic arthritis	0.000479	0.0024	CcSEcCtD
Toremifene—Oedema—Dexamethasone—psoriatic arthritis	0.000476	0.00238	CcSEcCtD
Toremifene—Oedema—Betamethasone—psoriatic arthritis	0.000476	0.00238	CcSEcCtD
Toremifene—Insomnia—Triamcinolone—psoriatic arthritis	0.000475	0.00237	CcSEcCtD
Toremifene—Insomnia—Methylprednisolone—psoriatic arthritis	0.000474	0.00237	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—psoriatic arthritis	0.00047	0.00235	CcSEcCtD
Toremifene—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000468	0.00234	CcSEcCtD
Toremifene—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000467	0.00234	CcSEcCtD
Toremifene—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000467	0.00234	CcSEcCtD
Toremifene—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000466	0.00233	CcSEcCtD
Toremifene—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000466	0.00233	CcSEcCtD
Toremifene—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00046	0.0023	CcSEcCtD
Toremifene—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00046	0.0023	CcSEcCtD
Toremifene—Vertigo—Prednisone—psoriatic arthritis	0.000456	0.00228	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—psoriatic arthritis	0.000456	0.00228	CcSEcCtD
Toremifene—Anorexia—Betamethasone—psoriatic arthritis	0.000454	0.00227	CcSEcCtD
Toremifene—Anorexia—Dexamethasone—psoriatic arthritis	0.000454	0.00227	CcSEcCtD
Toremifene—Fatigue—Triamcinolone—psoriatic arthritis	0.000452	0.00226	CcSEcCtD
Toremifene—Fatigue—Methylprednisolone—psoriatic arthritis	0.000451	0.00226	CcSEcCtD
Toremifene—Pain—Triamcinolone—psoriatic arthritis	0.000449	0.00224	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—psoriatic arthritis	0.000443	0.00221	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00044	0.0022	CcSEcCtD
Toremifene—Chills—Methotrexate—psoriatic arthritis	0.000438	0.00219	CcSEcCtD
Toremifene—Alopecia—Methotrexate—psoriatic arthritis	0.000431	0.00216	CcSEcCtD
Toremifene—Insomnia—Dexamethasone—psoriatic arthritis	0.000431	0.00215	CcSEcCtD
Toremifene—Insomnia—Betamethasone—psoriatic arthritis	0.000431	0.00215	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00043	0.00215	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—psoriatic arthritis	0.000427	0.00214	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—psoriatic arthritis	0.000425	0.00212	CcSEcCtD
Toremifene—Oedema—Prednisone—psoriatic arthritis	0.000415	0.00207	CcSEcCtD
Toremifene—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000414	0.00207	CcSEcCtD
Toremifene—Decreased appetite—Betamethasone—psoriatic arthritis	0.000414	0.00207	CcSEcCtD
Toremifene—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000411	0.00206	CcSEcCtD
Toremifene—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000411	0.00206	CcSEcCtD
Toremifene—Back pain—Methotrexate—psoriatic arthritis	0.000411	0.00205	CcSEcCtD
Toremifene—Fatigue—Betamethasone—psoriatic arthritis	0.00041	0.00205	CcSEcCtD
Toremifene—Fatigue—Dexamethasone—psoriatic arthritis	0.00041	0.00205	CcSEcCtD
Toremifene—Pain—Dexamethasone—psoriatic arthritis	0.000407	0.00204	CcSEcCtD
Toremifene—Pain—Betamethasone—psoriatic arthritis	0.000407	0.00204	CcSEcCtD
Toremifene—Nervous system disorder—Prednisone—psoriatic arthritis	0.000407	0.00203	CcSEcCtD
Toremifene—Skin disorder—Prednisone—psoriatic arthritis	0.000403	0.00201	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000401	0.00201	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—psoriatic arthritis	0.0004	0.002	CcSEcCtD
Toremifene—Anorexia—Prednisone—psoriatic arthritis	0.000395	0.00198	CcSEcCtD
Toremifene—Vertigo—Methotrexate—psoriatic arthritis	0.000381	0.00191	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—psoriatic arthritis	0.00038	0.0019	CcSEcCtD
Toremifene—Dizziness—Prednisolone—psoriatic arthritis	0.000377	0.00189	CcSEcCtD
Toremifene—Asthenia—Triamcinolone—psoriatic arthritis	0.000376	0.00188	CcSEcCtD
Toremifene—Asthenia—Methylprednisolone—psoriatic arthritis	0.000376	0.00188	CcSEcCtD
Toremifene—Insomnia—Prednisone—psoriatic arthritis	0.000375	0.00188	CcSEcCtD
Toremifene—Pruritus—Triamcinolone—psoriatic arthritis	0.000371	0.00186	CcSEcCtD
Toremifene—Pruritus—Methylprednisolone—psoriatic arthritis	0.00037	0.00185	CcSEcCtD
Toremifene—Chest pain—Methotrexate—psoriatic arthritis	0.000361	0.00181	CcSEcCtD
Toremifene—Decreased appetite—Prednisone—psoriatic arthritis	0.00036	0.0018	CcSEcCtD
Toremifene—Rash—Prednisolone—psoriatic arthritis	0.00036	0.0018	CcSEcCtD
Toremifene—Dermatitis—Prednisolone—psoriatic arthritis	0.000359	0.0018	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000359	0.0018	CcSEcCtD
Toremifene—Fatigue—Prednisone—psoriatic arthritis	0.000357	0.00179	CcSEcCtD
Toremifene—Headache—Prednisolone—psoriatic arthritis	0.000357	0.00179	CcSEcCtD
Toremifene—Constipation—Prednisone—psoriatic arthritis	0.000355	0.00177	CcSEcCtD
Toremifene—Dizziness—Triamcinolone—psoriatic arthritis	0.000347	0.00174	CcSEcCtD
Toremifene—Dizziness—Methylprednisolone—psoriatic arthritis	0.000346	0.00173	CcSEcCtD
Toremifene—Asthenia—Betamethasone—psoriatic arthritis	0.000342	0.00171	CcSEcCtD
Toremifene—Asthenia—Dexamethasone—psoriatic arthritis	0.000342	0.00171	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00034	0.0017	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000339	0.0017	CcSEcCtD
Toremifene—Nausea—Prednisolone—psoriatic arthritis	0.000339	0.0017	CcSEcCtD
Toremifene—Pruritus—Betamethasone—psoriatic arthritis	0.000337	0.00169	CcSEcCtD
Toremifene—Pruritus—Dexamethasone—psoriatic arthritis	0.000337	0.00169	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—psoriatic arthritis	0.000337	0.00168	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000335	0.00168	CcSEcCtD
Toremifene—Vomiting—Triamcinolone—psoriatic arthritis	0.000334	0.00167	CcSEcCtD
Toremifene—Vomiting—Methylprednisolone—psoriatic arthritis	0.000333	0.00167	CcSEcCtD
Toremifene—Rash—Triamcinolone—psoriatic arthritis	0.000331	0.00166	CcSEcCtD
Toremifene—Dermatitis—Triamcinolone—psoriatic arthritis	0.000331	0.00165	CcSEcCtD
Toremifene—Anorexia—Methotrexate—psoriatic arthritis	0.00033	0.00165	CcSEcCtD
Toremifene—Rash—Methylprednisolone—psoriatic arthritis	0.00033	0.00165	CcSEcCtD
Toremifene—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00033	0.00165	CcSEcCtD
Toremifene—Headache—Triamcinolone—psoriatic arthritis	0.000329	0.00164	CcSEcCtD
Toremifene—Headache—Methylprednisolone—psoriatic arthritis	0.000328	0.00164	CcSEcCtD
Toremifene—Dizziness—Betamethasone—psoriatic arthritis	0.000315	0.00158	CcSEcCtD
Toremifene—Dizziness—Dexamethasone—psoriatic arthritis	0.000315	0.00158	CcSEcCtD
Toremifene—Insomnia—Methotrexate—psoriatic arthritis	0.000313	0.00157	CcSEcCtD
Toremifene—Nausea—Triamcinolone—psoriatic arthritis	0.000312	0.00156	CcSEcCtD
Toremifene—Nausea—Methylprednisolone—psoriatic arthritis	0.000311	0.00156	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—psoriatic arthritis	0.000309	0.00155	CcSEcCtD
Toremifene—Vomiting—Dexamethasone—psoriatic arthritis	0.000303	0.00151	CcSEcCtD
Toremifene—Vomiting—Betamethasone—psoriatic arthritis	0.000303	0.00151	CcSEcCtD
Toremifene—Decreased appetite—Methotrexate—psoriatic arthritis	0.000301	0.00151	CcSEcCtD
Toremifene—Rash—Dexamethasone—psoriatic arthritis	0.0003	0.0015	CcSEcCtD
Toremifene—Rash—Betamethasone—psoriatic arthritis	0.0003	0.0015	CcSEcCtD
Toremifene—Dermatitis—Dexamethasone—psoriatic arthritis	0.0003	0.0015	CcSEcCtD
Toremifene—Dermatitis—Betamethasone—psoriatic arthritis	0.0003	0.0015	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000299	0.0015	CcSEcCtD
Toremifene—Fatigue—Methotrexate—psoriatic arthritis	0.000299	0.00149	CcSEcCtD
Toremifene—Headache—Betamethasone—psoriatic arthritis	0.000298	0.00149	CcSEcCtD
Toremifene—Headache—Dexamethasone—psoriatic arthritis	0.000298	0.00149	CcSEcCtD
Toremifene—Asthenia—Prednisone—psoriatic arthritis	0.000297	0.00149	CcSEcCtD
Toremifene—Pain—Methotrexate—psoriatic arthritis	0.000296	0.00148	CcSEcCtD
Toremifene—Pruritus—Prednisone—psoriatic arthritis	0.000293	0.00147	CcSEcCtD
Toremifene—Nausea—Dexamethasone—psoriatic arthritis	0.000283	0.00141	CcSEcCtD
Toremifene—Nausea—Betamethasone—psoriatic arthritis	0.000283	0.00141	CcSEcCtD
Toremifene—Dizziness—Prednisone—psoriatic arthritis	0.000274	0.00137	CcSEcCtD
Toremifene—Vomiting—Prednisone—psoriatic arthritis	0.000264	0.00132	CcSEcCtD
Toremifene—Rash—Prednisone—psoriatic arthritis	0.000261	0.00131	CcSEcCtD
Toremifene—Dermatitis—Prednisone—psoriatic arthritis	0.000261	0.00131	CcSEcCtD
Toremifene—Headache—Prednisone—psoriatic arthritis	0.00026	0.0013	CcSEcCtD
Toremifene—Asthenia—Methotrexate—psoriatic arthritis	0.000249	0.00124	CcSEcCtD
Toremifene—Nausea—Prednisone—psoriatic arthritis	0.000246	0.00123	CcSEcCtD
Toremifene—Pruritus—Methotrexate—psoriatic arthritis	0.000245	0.00123	CcSEcCtD
Toremifene—Dizziness—Methotrexate—psoriatic arthritis	0.000229	0.00115	CcSEcCtD
Toremifene—Vomiting—Methotrexate—psoriatic arthritis	0.00022	0.0011	CcSEcCtD
Toremifene—Rash—Methotrexate—psoriatic arthritis	0.000218	0.00109	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—psoriatic arthritis	0.000218	0.00109	CcSEcCtD
Toremifene—Headache—Methotrexate—psoriatic arthritis	0.000217	0.00109	CcSEcCtD
Toremifene—Nausea—Methotrexate—psoriatic arthritis	0.000206	0.00103	CcSEcCtD
